National Drug Early Warning System (NDEWS) Weekly Briefing

NDEWS ORIGINAL CONTENT

Substance use in the past 12 months: Washington DC, April 15–17, 2022

The National Drug Early Warning System (NDEWS) Rapid Street Reporting (RSR) team visited Washington DC on April 15-17, 2022. Interviews were conducted in various public spaces. The most commonly reported substances included alcohol, recreational marijuana, and medical marijuana. Of the participants surveyed a majority of persons were white (40.9%) and male (57.4%). The mean age of participants surveyed was 37 years old, and the mean years of education completed was 15.1 years. View the full report here.

Alert from the NDEWS Web Monitoring Team: Online mentions of MDPHP

What was found? Subreddit discussion for the drug MDPHP increased sharply in Spring 2022. In this recent trend, monthly total mention counts for MDPHP have diverged from new mention counts by unique commenters. This indicates new interest in MDPHP from commenters who were already aware of the drug in previous months/years.

To what does MDPHP refer? MDPHP is a cathinone. It was discovered in the 1960s and has been sold as a synthetic stimulant with the slang term "monkey dust".

How is it being discussed? Commenters discuss purchasing MDPHP in powder form. Many commenters describe MDPHP as inducing strong feelings of paranoia. In this recent trend, discussion has focused on side effects and administration routes.

Drug Terms: MDPHP, "monkeydust", "monkey dust".

NDEWS Methods to Detect New and Emerging Psychoactive Substances Presented by New and Emerging Scientists

Monday, June 13
3:45 PM - 5:15 PM
Room: Minneapolis ABC

Linda B. Cottler, PhD, MPH Co-Chair
PI, NDEWS; NIDA T32 Director; University of Florida

Marsha Lopez, PhD, MHS Co-Chair
Chief, Epidemiology Research Branch; National Institute on Drug Abuse, National Institutes of Health

Nicole Fitzgerald, BA Speaker
NIDA T32 Predoc Fellow; University of Florida
Drug Seizures and Poisoning Exposures: Collaborations with HIDTA and RADARS for Monitoring Trends in Drug Use and Availability in the U.S.

Nae Won, MPH Speaker
NIDA T32 Predoc Fellow; University of Florida
Rapid Street Reporting: Identifying Emerging Drugs and Their Adverse Effects in the Field

Paul Morris, MS Speaker
Doctoral Candidate; Florida Atlantic University
Web Monitoring of New Psychoactive Substance Trends in Drug Subreddit Discussion

Andrew McCabe, MPH Speaker
NIDA T32 Predoc Fellow; University of Florida
Real-Time 911 Dispatch Data to Monitor Overdose Events in the U.S.

Anna Wang, BS Moderator
NIDA T32 Predoc Fellow; University of Florida

IN THE NEWS

BC to decriminalize possession of small amounts of drugs such as cocaine, fentanyl, heroin, methamphetamine, and MDMA

Effective January 31, 2023, British Columbians 18 and older will be able to carry up to a cumulative total of 2.5 grams of cocaine, fentanyl, heroin, methamphetamine, and MDMA without the risk of arrest or criminal charges. Police are not to confiscate the drugs, and there is no requirement that people found to be in possession seek treatment. Possession will still be prohibited in personal vehicles or watercraft operated by a minor, regardless of whether or not the vehicle or watercraft is in motion. Read the full article here.

Placement of six synthetic cathinones in Schedule I

The Drug Enforcement Administration permanently placed six synthetic cathinones in Schedule I of the Controlled Substances Act effective June 1, 2022. The substances include:

• N-ethylhexedrone

• alpha-pyrrolidinohexanophenone

• 4-methyl-alpha-ehtylaminopentiophenone

• 4'-methyl-alpha-pyrrolidinohexiophenone

• alpha-pyrrolidinoheptaphenone

• 4'chloro-alpha-pyrrolidinovalerophenone

Read the full scheduling here.

Share your research, news, and events through our submission form

Share your comments on our newsletter through our feedback form

Follow NDEWS on Twitter: @NDEWSnews